- Evaluated acquisition candidates in $6.2B pharma R&D market, including valuations and deal structure for M&A opportunities
- Analyzed the target company's historical financial, technology, strategic rationale and potential synergies
- Explored green hydrogen market using multiple resources and identified a $40M/GW automation opportunity for Emerson